Market revenue in 2023 | USD 908.7 million |
Market revenue in 2030 | USD 1,526.6 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Proteases |
Fastest growing segment | Proteases |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Proteases |
Key market players worldwide | Biocatalysts Ltd, Merck KGaA, Codexis Inc, Roche Holding AG, Amano Enzyme, Advanced Enzymes, Amicogen, Dyadic International Inc, BBI Solutions, Affymetrix, American Laboratories, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro diagnostics enzymes market will help companies and investors design strategic landscapes.
Proteases was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the North America in-vitro diagnostics enzymes market based on proteases covering the revenue growth of each sub-segment from 2018 to 2030.
North America occupied the largest market share in 2019 owing to high demand for IVD enzymes and increasing prevalence of infectious disorders in the region. To combat with the ongoing COVID19 pandemic, FDA has issued emergency use authorizations for in vitro COVID-19 laboratory developed tests.
In addition, most of these emergency use authorizations are enzyme-linked immunosorbent assay and Reverse Transcription Polymerase Chain Reaction (RT-PCR)-based tests for the detection of SARS-CoV-2.
Owing to the high usability of enzymes during RT-PCR, the development of such tests is expected to generate revenue in the North American market. Rise in the number of cancer cases and adoption of enzymes for histopathology of biopsy samples are also factors expected to propel market growth in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America in-vitro diagnostics enzymes market, including forecasts for subscribers. This continent databook contains high-level insights into North America in-vitro diagnostics enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account